Biocept (BIOC) has potential to reach $1
Biocept Inc (BIOC) currently trades at $0.27 and has fallen by 2.17% today. Biocept has just released its latest annual results, and the shares gained 4.4% to US$0.28. It was a pretty bad result overall; while revenues were in line with expectations at US$5.5m, statutory losses exploded to US$1.22 per share. Following the result, the analyst has updated their earnings model, and it would be good to know whether they think there’s been a strong change in the company’s prospects, or if it’s business as usual.
Based on this information, investorsQ rates this stock 5 out of 10. We give it this rating because the business will grow faster than the wider industry. The high forecast for Biocept Inc is $1.00 and the low is $0.10. Notably, the company’s market cap is $29.75 million with a 52 week high of $2.11 and a 52 week low of $0.21.